Preparing the published article.
Company Profile: Ekso Bionics Rehabilitation and Mobility
A current-source profile of EksoNR and Ekso Indego Personal, distinguishing clinical and supervised personal use, regional requirements, training and procurement considerations during a corporate transition.
1. Business focus and current corporate context
Ekso Bionics develops wearable exoskeleton technology for rehabilitation and mobility. Its healthcare offerings include EksoNR for rehabilitation settings and Ekso Indego Personal for qualified home and community users. These are distinct purchasing and supervision pathways, rather than interchangeable versions of one device. Official healthcare portfolio.
Corporate identity changed in 2026. ChronoScale's annual report describes the legacy Ekso business within its group and a plan to divest it. This profile concerns that rehabilitation business and its products; an inquiry should confirm the legal contracting entity and responsible service organization. 2026 corporate filing.
2. EksoNR and therapist-controlled gait work
EksoNR is a wearable robotic exoskeleton for clinical rehabilitation. Its current product page describes GaitCoach feedback, therapist adjustment of swing and stance assistance, and activities such as weight shifting and stepping in place before walking. Session data include walking time, distance and speed, with a cloud dashboard for review. The therapist remains responsible for treatment decisions. EksoNR features.
The manufacturer states that EksoNR is available through certified rehabilitation centers and is not sold for personal home use. A hospital demonstration should test fitting, transfers, clinician controls, reporting and device movement between treatment spaces with the intended team. Those workflow questions are part of procurement evaluation, not a promise of faster recovery or a fixed number of steps per session. Clinical-use boundary.
3. Ekso Indego Personal and supervised community use
Ekso Indego Personal is a powered lower-limb orthosis with motors at the hips and knees and a modular design for handling and transport. Its published home-and-community scope includes spinal cord injury levels T3 to L5. The product page explicitly requires a support person to complete training with the user and be present during use. References to independence should not be interpreted as permission for unsupervised operation. Personal device and companion requirements.
The indications page distinguishes personal and rehabilitation-institution use, including separate injury-level and functional criteria. It also states that Indego is not intended for sports or stair climbing. A clinical trial session does not by itself establish eligibility to acquire and use a device at home. Indego indications and use settings.
4. Eligibility and regional labeling
For the USA, Ekso's EksoNR indications list multiple sclerosis, acquired brain injury including stroke, and specified spinal cord injury groups. They include upper-limb motor-function requirements and, for the C7-to-T3 spinal cord injury group, an ASIA D condition. Use is under a trained physical therapist in rehabilitation institutions; sports and stair climbing are excluded. The same page provides a separate EU intended-use description. Published US and EU indications.
A buyer should obtain the current local instructions and supporting device documentation for the exact model, software and intended population. This overview is not a complete screening checklist or proof of authorization in another country. A company's public indication summary should not be substituted for the institution's review of contraindications, fit and supervision requirements.
5. Training and programme readiness
The current training page separates EksoNR with GaitCoach, GaitCoach+ training, Indego specialist training and legacy EksoNR training. It also describes a personal-use trainer pathway for screening and preparing users and their companions. This distinction matters when comparing a new quotation with an older training manual. Current training pathways.
Before purchase, ask which course matches the supplied release, who may operate the device after each stage, how new staff are trained and how competencies are documented. Confirm available languages, local professional-education recognition and the cost of repeat training. Supplier training does not replace professional licensure or the facility's clinical governance.
6. Provider examples and dated business developments
As viewed on 10 September 2026, Select Medical Rehabilitation Hospital's technology page lists an Ekso Bionics exoskeleton at Select Rehabilitation of Denton and its rehabilitation hospital at Lutheran Hospital. This is an operator's own service listing. It does not identify the precise model, installation date or current appointment capacity, so those details should be checked directly with the facility. Provider technology listing.
ChronoScale's report for the year ended 31 May 2026 documents the May business combination and classifies legacy Ekso as held for sale. A planned divestiture is not a completed sale or a statement that products have stopped operating. For a new contract, ask who will honor warranties, maintain software and supply parts through any ownership transition. Dated corporate status and sale plan.
7. Commercial contact and a usable procurement brief
Ekso's official contact page lists its San Rafael office, a European office in Ratingen, Germany, and general and technical-support routes. Its distributor directory provides additional territory contacts. Use these to establish the responsible sales and service team; a listed territory does not mean every product is available there. Official contacts; Distributor directory.
A useful brief states the intended care setting, patient population, exact device, software, staffing model and country. Request line items for training, fitting accessories, batteries, maintenance, reporting access, shipping and support. For a personal device, confirm assessment and companion-training arrangements. Any reimbursement question requires a separate determination for the individual and payer; this profile does not promise insurance coverage or a public price.
8. Source limits and related resources
Reviewed on 10 September 2026. Manufacturer pages describe the products and their published use conditions; the provider page documents its service listing; the corporate filing supplies dated ownership context. None is used here to guarantee recovery, comparative efficacy or commercial availability. Product generations, clinical and personal use, and country-specific requirements remain separate.
Explore medical robotics, Write a Robotics Buyer Brief and Robotics RFQ.